President Donald Trump’s physical Dr. Sean Conley confirmed Friday that the president is taking an experimental antibody treatment to help him fight the coronavirus following his diagnosis this ...
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced initiation of the first clinical trial of REGN-COV2, its investigational dual antibody cocktail for the prevention and treatment of COVID ...
A cocktail of two drugs developed by Regeneron Pharmaceuticals was able to reduce viral loads and improve symptoms in patients who had Covid-19, but had not been hospitalized, according to new results ...
CNN — President Trump received a high dose of an experimental antibody cocktail from Regeneron as part of his Covid-19 treatment. Now the drugmaker's stock is up sharply -- and questions are swirling ...
Nov 17 (Reuters) - Roche Holding AG (ROG.S), opens new tab has completed early tests of its ability to produce large quantities of Regeneron Pharmaceuticals Inc's (REGN.O), opens new tab COVID-19 ...
Dr. Sanjay Sethi, director of the University at Buffalo Clinical Research Office, holds a vial of monoclonal antibody cocktail REGN-COV2, manufactured by Regeneron Pharmaceuticals. Some Western New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results